Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents

doi:10.3748/wjg.v21.i11.3308

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9261)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

611

WORD

214

HTML

4716

Figures (1-2)

272

Tables (1-5)

228

Sum=6041

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1493

Download

1727

Sum=3220

Mar 21, 2015 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 21, 2015; 21(11): 3308-3316
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3308

Full Size Figure Download Figure

Figure 2 Clinical symptoms (A) and involvement locations (B) of active tuberculosis infection after anti-TNF therapy in patients with inflammatory bowel disease.

Citation: Kim ES, Song GA, Cho KB, Park KS, Kim KO, Jang BI, Kim EY, Jeon SW, Lee HS, Yang CH, Lee YK, Lee DW, Kim SK, Kim TO, Lee J, Kim HW, Jee SR, Park SJ, Kim HJ. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. World J Gastroenterol 2015; 21(11): 3308-3316
URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3308.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3308